Identification and characterization of steroidogenic Factor-1 inverse agonists

Methods in Enzymology

Volumn 485, Issue C, 2010, Pages 3-23

  Doghman, Mabrouka ^a   Madoux, Franck ^b   Hodder, Peter ^b   Lalli, Enzo ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adrenal cortex; Cancer; Proliferation; SF 1

Indexed keywords

STEROID; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX TUMOR; BOOK; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CHO CELL; CYTOTOXICITY; GENETIC TRANSFECTION; HORMONE SYNTHESIS; HUMAN; INVERSE AGONISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; TUMOR CELL; VIRILIZATION;

MUS MUSCULUS;

EID: 78049508016     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381296-4.00001-4     Document Type: Chapter

References (27)

1. Almeida M.Q., Soares I.C., Ribeiro T.C., Fragoso M.C., Marins L.V., Wakamatsu A., Ressio R.A., Nishi M.Y., Jorge A.A., Lerario A.M., Alves V.A., Mendonca B.B., et al. Steroidogenic Factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J. Clin. Endocrinol. Metab. 2010, 95:1458-1462.
2. Campbell L.A., Faivre E.J., Show M.D., Ingraham J.G., Flinders J., Gross J.D., Ingraham H.A. Decreased recognition of SUMO-sensitive target genes following modification of SF-1 (NR5A1). Mol. Cell. Biol. 2008, 28:7476-7486.
3. Chen W.Y., Lee W.C., Hsu N.C., Huang F., Chung B.C. SUMO modification of repression domains modulates function of nuclear receptor 5A1 (Steroidogenic Factor-1). J. Biol. Chem. 2004, 279:38730-38735.
4. Del Tredici A.L., Andersen C.B., Currier E.A., Ohrmund S.R., Fairbain L.C., Lund B.W., Nash N., Olsson R., Piu F. Identification of the first synthetic Steroidogenic Factor 1 inverse agonists: Pharmacological modulation of steroidogenic enzymes. Mol. Pharmacol. 2008, 73:900-908.
5. Doghman M., Karpova T., Rodrigues G.A., Arhatte M., De Moura J., Cavalli L.R., Virolle V., Barbry P., Zambetti G.P., Figueiredo B.C., Heckert L.L., Lalli E. Increased Steroidogenic Factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol. Endocrinol. 2007, 21:2968-2987.
6. Doghman M., Cazareth J., Douguet D., Madoux F., Hodder P., Lalli E. Inhibition of adrenocortical carcinoma cell proliferation by Steroidogenic Factor-1 inverse agonists. J. Clin. Endocrinol. Metab. 2009, 94:2178-2183.
7. Figueiredo B.C., Cavalli L.R., Pianovski M.A., Lalli E., Sandrini R., Ribeiro R.C., Zambetti G., DeLacerda L., Rodrigues G.A., Haddad B.R. Amplification of the Steroidogenic Factor 1 gene in childhood adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 90:615-619.
8. Hammer G.D., Krylova I., Zhang Y., Darimont B.D., Simpson K., Weigel N.L., Ingraham H.A. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: Integration of hormone signaling in reproduction and stress. Mol. Cell 1999, 3:521-526.
9. Hodder P., Cassaday J., Peltier R., Berry K., Inglese J., Feuston B., Culberson C., Bleicher L., Cosford N.D., Bayly C., Suto C., Varney M., et al. Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system. Anal. Biochem. 2003, 313:246-254.
10. Hoivik E.A., Lewis A.E., Aumo L., Bakke M. Molecular aspects of Steroidogenic Factor 1 (SF-1). Mol. Cell. Endocrinol. 2010, 315:27-39.
11. Kakidani H., Ptashne M. GAL4 activates gene expression in mammalian cells. Cell 1988, 52:161-167.
12. Komatsu T., Mizusaki H., Mukai T., Ogawa H., Baba D., Shirakawa M., Hatakeyama S., Nakayama K.I., Yamamoto H., Kikuchi A., Morohashi K.-I. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 2004, 18:2451-2462.
13. Krylova I.N., Sablin E.P., Moore J., Xu R.X., Waitt G.M., MacKay J.A., Juzumiene D., Bynum J.M., Madauss K., Montana V., Lebedeva L., Suzawa M., et al. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 2005, 120:343-355.
14. Lalli E. Adrenocortical development and cancer: Focus on SF-1. J. Mol. Endocrinol. 2010, 44:301-307.
15. Lee M.B., Lebedeva L.A., Suzawa M., Wadekar S.A., Desclozeaux M., Ingraham H.A. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol. Cell. Biol. 2005, 25:1879-1890.
16. Lewis A.E., Rusten M., Hoivik E.A., Vikse E.L., Hansson M.L., Wallberg A.E., Bakke M. Phosphorylation of Steroidogenic Factor 1 is mediated by cyclin-dependent kinase 7. Mol. Endocrinol. 2008, 22:91-104.
17. Li Y., Choi M., Cavey G., Daugherty J., Suino K., Kovach A., Bingham N.C., Kliewer S.A., Xu H.E. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor Steroidogenic Factor-1. Mol. Cell 2005, 17:491-502.
18. Madoux F., Li X., Chase P., Zastrow G., Cameron M.D., Conkright J.J., Griffin P.R., Thacher S., Hodder P. Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Mol. Pharmacol. 2008, 73:1776-1784.
19. Pianovski M.A., Cavalli L.R., Figueiredo B.C., Santos S.C., Doghman M., Ribeiro R.C., Oliveira A.G., Michalkiewicz E., Rodrigues G.A., Zambetti G., Haddad B.R., Lalli E. SF-1 overexpression in childhood adrenocortical tumours. Eur. J. Cancer 2006, 42:1040-1043.
20. Roth J., Madoux F., Hodder P., Roush W.R. Synthesis of small molecule inhibitors of the orphan nuclear receptor steroidogenic factor-1 (NR5A1) based on isoquinolinone scaffolds. Bioorg. Med. Chem. Lett. 2008, 18:2628-2632.
21. Schimmer B.P., White P.C. Minireview: Steroidogenic Factor 1: its roles in differentiation, development, and disease. Mol. Endocrinol. 2010, 24:1322-1337.
22. Urs A.N., Dammer E., Sewer M.B. Sphingosine regulates the transcription of CYP17 by binding to Steroidogenic Factor-1. Endocrinology 2006, 147:5249-5258.
23. Wang W., Zhang C., Marimuthu A., Krupka H.I., Tabrizizad M., Shelloe R., Mehra U., Eng K., Nguyen H., Settachatgul C., Powell B., Milburn M.V., et al. The crystal structures of human Steroidogenic Factor-1 and Liver Receptor Homologue-1. Proc. Natl. Acad. Sci. USA 2005, 102:7505-7510.
24. Whitby R.J., Dixon S., Maloney P.R., Delerive P., Goodwin B.J., Parks D.J., Willson T.M. Identification of small molecule agonists of the orphan nuclear receptors Liver Receptor Homolog-1 and Steroidogenic Factor-1. J. Med. Chem. 2006, 49:6652-6655.
25. Wilson T.E., Fahrner T.J., Milbrandt J. The orphan receptors NGFI-B and Steroidogenic Factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol. Cell. Biol. 1993, 13:5794-5804.
26. Winnay J.N., Hammer G.D. Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of Steroidogenic Factor 1-dependent transcriptional activation. Mol. Endocrinol. 2006, 20:147-166.
27. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.